10-QPeriod: Q1 FY2022

MICROCHIP TECHNOLOGY INC Quarterly Report for Q1 Ended Jun 30, 2021

Filed August 3, 2021For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) reported strong financial results for the quarter ended June 30, 2021, driven by robust demand across its semiconductor product lines. Net sales increased by 19.8% year-over-year to $1.57 billion, with significant growth in Microcontrollers and Analog products. The company maintained a healthy gross profit margin of 64.2%, an improvement from 61.0% in the prior year, benefiting from increased capacity utilization and favorable product mix. Operating income saw substantial growth, increasing from $218.3 million to $368.8 million. Despite persistent supply chain constraints expected to continue through mid-2022, Microchip demonstrated strong operational execution. The company generated robust operating cash flow of $629.9 million, supporting investments in capital expenditures, which increased to $86.3 million to expand production capacity. The balance sheet remains solid, with total assets of $16.28 billion and total liabilities and stockholders' equity of $16.28 billion. The company also continues to return capital to shareholders through dividends.

Financial Statements
Beta
Revenue$1.57B
Cost of Revenue$561.80M
Gross Profit$1.01B
R&D Expenses$238.40M
SG&A Expenses$174.30M
Operating Expenses$638.80M
Operating Income$368.80M
Interest Expense$72.30M
Net Income$252.80M
EPS (Basic)$0.46
EPS (Diluted)$0.45
Shares Outstanding (Basic)547.50M
Shares Outstanding (Diluted)565.10M

Key Highlights

  • 1Net sales increased 19.8% year-over-year to $1.57 billion, driven by strong demand in microcontroller and analog product lines.
  • 2Gross profit margin improved to 64.2% from 61.0% in the prior year, attributed to higher capacity utilization and favorable product mix.
  • 3Operating income significantly increased by 68.7% to $368.8 million.
  • 4Net income more than doubled to $252.8 million, resulting in diluted EPS of $0.89, up from $0.48 in the prior year.
  • 5Operating cash flow remained strong at $629.9 million, reflecting healthy cash generation.
  • 6Capital expenditures increased to $86.3 million, reflecting investments in production capacity expansion.
  • 7Supply chain constraints are expected to persist through mid-calendar 2022, but the company is actively managing capacity.

Frequently Asked Questions